https://vrdct.bio/ https://vrdct.bio/vlp https://vrdct.bio/markets https://vrdct.bio/research https://vrdct.bio/research/briefs https://vrdct.bio/research/programs https://vrdct.bio/catalysts https://vrdct.bio/liquidity https://vrdct.bio/edge https://vrdct.bio/docs https://vrdct.bio/about https://vrdct.bio/launch https://vrdct.bio/markets/ntla-2027-03-10 https://vrdct.bio/companies/ntla https://vrdct.bio/drugs/ntla-lonvo-z https://vrdct.bio/events/ntla-2027-03-10 https://vrdct.bio/markets/blte-2027-02-12 https://vrdct.bio/companies/blte https://vrdct.bio/drugs/blte-tinlarebant https://vrdct.bio/events/blte-2027-02-12 https://vrdct.bio/markets/dyn-2027-01-21 https://vrdct.bio/companies/dyn https://vrdct.bio/drugs/dyn-z-rostudirsen https://vrdct.bio/events/dyn-2027-01-21 https://vrdct.bio/markets/axsm-2027-05-01 https://vrdct.bio/companies/axsm https://vrdct.bio/drugs/axsm-axs-12 https://vrdct.bio/events/axsm-2027-05-01 https://vrdct.bio/markets/bbio-2027-05-08 https://vrdct.bio/companies/bbio https://vrdct.bio/drugs/bbio-encaleret https://vrdct.bio/events/bbio-2027-05-08 https://vrdct.bio/markets/exel-2027-03-03 https://vrdct.bio/companies/exel https://vrdct.bio/drugs/exel-zanzalintinib-atezolizumab https://vrdct.bio/events/exel-2027-03-03 https://vrdct.bio/markets/phvs-2027-04-23 https://vrdct.bio/companies/phvs https://vrdct.bio/drugs/phvs-deucrictibant https://vrdct.bio/events/phvs-2027-04-23 https://vrdct.bio/markets/inbx-2027-04-14 https://vrdct.bio/companies/inbx https://vrdct.bio/drugs/inbx-ozekibart https://vrdct.bio/events/inbx-2027-04-14 https://vrdct.bio/markets/uncy-2027-03-25 https://vrdct.bio/companies/uncy https://vrdct.bio/drugs/uncy-oxylanthanum-carbonate https://vrdct.bio/events/uncy-2027-03-25 https://vrdct.bio/markets/gild-2027-02-02 https://vrdct.bio/companies/gild https://vrdct.bio/drugs/gild-oral-lenacapavir https://vrdct.bio/events/gild-2027-02-02 https://vrdct.bio/research/events/reg-cytk-aficamten-maple-hcm https://vrdct.bio/research/events/reg-capr-deramiocel-dmd https://vrdct.bio/research/events/reg-svra-molgramostim-apap https://vrdct.bio/research/events/reg-bbio-bbp418-lgmd https://vrdct.bio/research/events/reg-cogt-bezuclastinib-gist https://vrdct.bio/research/events/reg-vrtx-povetacicept-igan https://vrdct.bio/research/events/reg-exel-zanzalintinib-crc https://vrdct.bio/research/events/reg-axsm-axs12-cataplexy https://vrdct.bio/research/events/bio-nct06383390 https://vrdct.bio/research/events/bio-nct06077864 https://vrdct.bio/research/events/bio-nct07037433 https://vrdct.bio/research/events/bio-nct07868939 https://vrdct.bio/research/events/bio-nct07795164 https://vrdct.bio/research/events/bio-nct06215716 https://vrdct.bio/research/events/bio-nct06419374 https://vrdct.bio/research/events/bio-nct04849728 https://vrdct.bio/research/events/bio-nct07863193 https://vrdct.bio/research/events/bio-nct06672237 https://vrdct.bio/research/events/reg-ntla-lonvoz-hae https://vrdct.bio/research/events/bio-nct07839936 https://vrdct.bio/research/events/bio-nct07204275 https://vrdct.bio/research/events/bio-nct06767514 https://vrdct.bio/research/events/bio-nct06305754 https://vrdct.bio/research/events/bio-nct06357533 https://vrdct.bio/research/events/bio-nct07060807 https://vrdct.bio/research/events/bio-nct06380751 https://vrdct.bio/research/events/bio-nct06653153 https://vrdct.bio/research/events/bio-nct07717411 https://vrdct.bio/research/events/bio-nct07174310 https://vrdct.bio/research/events/bio-nct07690371 https://vrdct.bio/research/events/bio-nct05531565 https://vrdct.bio/research/events/bio-nct06628908 https://vrdct.bio/research/events/bio-nct06880770 https://vrdct.bio/research/events/bio-nct07613294 https://vrdct.bio/research/events/bio-nct05581303 https://vrdct.bio/research/events/bio-nct06677060 https://vrdct.bio/research/events/bio-nct07219602 https://vrdct.bio/research/events/lly-2026-revenue https://vrdct.bio/research/events/lly-2026-adjusted-eps https://vrdct.bio/research/events/nvo-2026-adjusted-sales-growth https://vrdct.bio/research/events/mrk-2026-sales https://vrdct.bio/research/events/mrk-2026-adjusted-eps https://vrdct.bio/research/events/abbv-2026-adjusted-eps https://vrdct.bio/research/events/amgn-q3-2026-gaap-profit https://vrdct.bio/research/events/gild-2026-product-sales https://vrdct.bio/research/events/gild-pepstar-program-acquisition https://vrdct.bio/research/events/bmy-2026-revenue https://vrdct.bio/research/events/bmy-2026-adjusted-eps https://vrdct.bio/research/events/regn-2026-rd-spending https://vrdct.bio/research/events/regn-q4-2026-eylea-hd-sales https://vrdct.bio/research/events/biib-2026-adjusted-eps https://vrdct.bio/research/events/biib-2026-operating-investment https://vrdct.bio/research/events/azn-2026-cer-revenue-growth https://vrdct.bio/research/events/alny-2026-product-revenue https://vrdct.bio/research/events/alny-2026-ttr-sales https://vrdct.bio/research/events/ntla-2026-year-end-cash https://vrdct.bio/research/events/crsp-2026-year-end-cash https://vrdct.bio/research/events/srpt-2026-product-revenue https://vrdct.bio/research/events/srpt-2026-operating-expense https://vrdct.bio/research/events/ions-2026-year-end-cash https://vrdct.bio/research/events/insm-2026-brinsupri-sales https://vrdct.bio/research/events/insm-2026-year-end-cash https://vrdct.bio/research/events/nbix-2026-ingrezza-sales https://vrdct.bio/research/events/nbix-2026-gaap-rd https://vrdct.bio/research/events/beam-q4-2026-rd https://vrdct.bio/research/events/exel-2026-product-revenue https://vrdct.bio/research/events/exel-2026-rd https://vrdct.bio/research/events/incy-2026-net-sales https://vrdct.bio/research/events/incy-2026-opzelura-sales https://vrdct.bio/research/events/uthr-q3-2026-tyvaso-sales https://vrdct.bio/research/events/bmrn-q3-2026-gaap-profit https://vrdct.bio/research/events/airna-air001-first-clinical-results https://vrdct.bio/research/events/arbor-abo101-redephine-data https://vrdct.bio/research/events/arbor-abo201-clinical-clearance https://vrdct.bio/research/events/arbor-abo202-clinical-clearance https://vrdct.bio/research/events/tune401-larger-phase2-first-dose https://vrdct.bio/research/events/tune401-phase2-primary-report https://vrdct.bio/research/events/tessera-tsra196-first-us-dose https://vrdct.bio/research/events/tessera-tsra196-human-aat-data https://vrdct.bio/research/events/ascidian-acdn01-pediatric-dose https://vrdct.bio/research/events/ascidian-acdn01-longterm-retinal-data https://vrdct.bio/research/events/epicrispr-epi321-twelve-month-data https://vrdct.bio/research/events/epicrispr-epi331-first-human-dose https://vrdct.bio/research/events/repronovo-rpn001-phase2-data https://vrdct.bio/research/events/repronovo-rpn002-implantation-data https://vrdct.bio/research/events/repronovo-rpn002-adenomyosis-trial https://vrdct.bio/research/events/eradivir-ev25-natural-influenza-readout https://vrdct.bio/research/events/eradivir-ev148-first-human-dose https://vrdct.bio/research/events/adcentrx-adrx0405-phase1a-completion https://vrdct.bio/research/events/adcentrx-adrx0706-expansion-readout https://vrdct.bio/research/events/artbio-ab001-artisan-readout https://vrdct.bio/research/events/artbio-ab001-phase2-first-dose https://vrdct.bio/research/events/mirador-kp301-aav-first-dose https://vrdct.bio/research/events/imvax-igv001-sno2026-full-report https://vrdct.bio/research/events/imvax-igv001-phase3-first-dose https://vrdct.bio/research/events/verdiva-vrb101-evolve2-topline https://vrdct.bio/research/events/verdiva-vrb101-phase3-first-dose https://vrdct.bio/research/events/verdiva-vrb103-phase1-data https://vrdct.bio/research/events/adcytherix-adcx020-dose-optimization https://vrdct.bio/research/events/peptinovo-pnb281-first-human-dose https://vrdct.bio/research/events/alentis-lixudebart-renal-primary-data https://vrdct.bio/research/events/alentis-lixudebart-aav-phase3-first-dose